CompletedInterventionalPhase 2Last updated Dec 2, 2015

Dose-Response Curve: Interventions to Prevent and Treat Radiodermatitis

Use of Chamomilla Recutita Gel and Urea Cream to Prevent and Treat Radiodermatitis: Phase 2 Study

Overview

ClinicalTrials.gov ID: NCT02249884
Lead Sponsor: University of BrasiliaOTHER
Brief Summary: Dose response curve to define the security and tolerable dose to be used for prevention and treatment of radiodermatitis in patients with breast or head and neck cancer.
Study Type: Interventional

Status

Study Record Dates

NCT02251392Unknown status

Evaluation of Therapeutic Efficacy in Use of Chamomilla Gel, Chamomilla Infuse and Urea in Radiodermatitis

NCT02247830Completed

Management Radiodermatitis in Patients With Breast or Head and Neck Cancer

NCT03494205Completed

Urtica Comp. Gel for Prevention and Therapy of Radiation Dermatitis

NCT05886673Unknown status

Development of a Protective Cream Against Radiodermatitis Caused by Radiotherapy.

NCT02556632Completed

Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer

NCT01701466Terminated

Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis